2. Signaling Pathways
  3. GPCR/G Protein
  4. Angiotensin Receptor
  5. Angiotensin Receptor Antagonist

Angiotensin Receptor Antagonist

Angiotensin Receptor Isoform Comparison

Angiotensin Receptor Antagonists (107):

Cat. No. Product Name Effect Purity
  • HY-131276R
    Olmesartan lactone impurity (Standard)
    		Antagonist
    Olmesartan lactone impurity (Standard) is the analytical standard of Olmesartan lactone impurity. This product is intended for research and analytical applications. Olmesartan lactone impurity is a cyclic ester impurity of Olmesartan. Olmesartan is an angiotensin II receptor (AT1R) antagonist and has the potential for high blood pressure study.
  • HY-133775
    Olmesartan impurity
    		Antagonist
    Olmesartan impurity is an Olmesartan impurity. Olmesartan (RNH-6270) is an angiotensin II receptor (AT1R) antagonist has the potential for high blood pressure study.
  • HY-167886
    GA 0113
    		Antagonist
    GA 0113 is a potent and orally active angiotensin II (Ang II) AT1-receptor antagonist. GA 0113 inhibits the Ang II (HY-13948)-induced pressor response with ID50 of 0.032 mg/kg and dose-dependently increases plasma renin activity for 48 h.
  • HY-14736R
    Azilsartan medoxomil (Standard)
    		Antagonist
    Azilsartan medoxomil (Standard) is the analytical standard of Azilsartan medoxomil. This product is intended for research and analytical applications. Azilsartan medoxomil (TAK 491) is an orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM, which used in the treatment of adults with essential hypertension.
  • HY-U00245
    L162441
    		Antagonist
    L162441 is an Angiotensin type 1 receptor antagonist.
  • HY-U00202
    LY285434
    		Antagonist
    LY285434 is a suitable angiotensin II receptor antagonist.
  • HY-U00188
    A81988
    		Antagonist
    A81988 is a potent, competitive, non-peptidic antagonist of angiotensin AT1 receptors.